NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Juan M. Hincapie-Castillo: FDA Releases Draft 2026 Guidance Plans Including Endometriosis-Associated Pain
Juan M. Hincapie-Castillo/LinkedIn
Feb 28, 2026, 03:58

Juan M. Hincapie-Castillo: FDA Releases Draft 2026 Guidance Plans Including Endometriosis-Associated Pain

Juan M. Hincapie-Castillo, Associate Professor at University of Pittsburgh, shared a post on LinkedIn:

“The FDA Center for Drug Evaluation and Research released its New and Revised Draft Guidances Planned for Publication in CY 2026.

A few that stand out to me working in RWE, drug safety, and pain:

  • Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
  • Considerations for the Inclusion of Older Adults in Clinical Trials
  • Endometriosis-Associated Pain: Establishing Effectiveness and Safety of Drugs for Management
  • Sickle Cell Disease: Endpoints for the Development of Products for Prevention and Treatment of SCD Complications
  • Development of a Shared System or Separate REMS.”

Proceed to the pages attached to the post.

Stay updated on all scientific advances in the field of fertility with Fertility News.

Clinical Trials Effectiveness and Safety of Drugs for Management endometriosis Endometriosis-Associated Pain FDA FDA Center for Drug Evaluation and Research FDA-Regulated Medical Products Fertility Fertility News Juan M. Hincapie-Castillo race and ethnicity reproductive health Reproductive Medicine RWE Sickle Cell Disease
NewsFeed